179 filings
8-K
TVTX
Travere Therapeutics Inc
24 Apr 24
Other Events
4:05pm
8-K
TVTX
Travere Therapeutics Inc
23 Feb 24
Other Events
4:05pm
8-K
TVTX
Travere Therapeutics Inc
15 Feb 24
Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
8-K
TVTX
Travere Therapeutics Inc
8 Jan 24
Travere Therapeutics Provides Corporate Update and 2024 Outlook
7:07am
8-K
TVTX
Travere Therapeutics Inc
4 Dec 23
Cost Associated with Exit or Disposal Activities
4:10pm
8-K
99mc ui49v
7 Nov 23
Travere Therapeutics Reports Third Quarter 2023 Financial Results
4:04pm
8-K
b1g3y7j l0jz9883akr4
21 Sep 23
Other Events
7:35am
8-K
dfejy2 vy621kkecp
5 Sep 23
Completion of Acquisition or Disposition of Assets
8:35am
8-K
ldfkpeq86 r1p
3 Aug 23
Travere Therapeutics Reports Second Quarter 2023 Financial Results
4:06pm
8-K
unrr fglncu0s95a5mq
17 Jul 23
Entry into a Material Definitive Agreement
8:07am
8-K
pgb762l35ydx
31 May 23
Other Events
4:57pm
8-K
erc rltlegpv
22 May 23
Departure of Directors or Certain Officers
4:30pm
8-K
06g8w8e9fiu8uw55 5n7
4 May 23
Travere Therapeutics Reports First Quarter 2023 Financial Results
4:05pm
8-K
d9kv2oyu
1 May 23
Other Events
4:07pm
8-K
5yxj4v p98y
12 Apr 23
Changes in Registrant's Certifying Accountant
4:30pm
8-K
vof3snxtutcticl
1 Mar 23
Travere Therapeutics Announces Proposed Public Offering of Common Stock
5:17pm
8-K
0mri1 xq22p5ia
23 Feb 23
Travere Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
4:05pm
8-K
59uqnpyurc
17 Feb 23
Other Events
4:06pm
8-K
zal9wv308sjg 63q4gt
9 Jan 23
Travere Therapeutics Provides Corporate Update and 2023 Outlook
7:05am
8-K
1rznrw8za1v tixi
27 Oct 22
Travere Therapeutics Reports Third Quarter 2022 Financial Results
4:17pm